New patent for Alkermes Inc drug LYBALVIBy DrugPatentWatch – Make Better Decisions / April 25, 2024 Annual Drug Patent Expirations for LYBALVI Lybalvi is a drug marketed by Alkermes Inc and is included in one NDA. It is available from one supplier. There are twelve patents…Source